Best Tests for Diagnosing Lupus
The best diagnostic approach for lupus includes antinuclear antibody (ANA) testing as the initial screening test, followed by more specific tests including anti-dsDNA and anti-Sm antibodies to confirm the diagnosis. 1
Initial Screening Test
- ANA testing using indirect immunofluorescence on HEp-2 cells is the most sensitive screening test for lupus with nearly 100% sensitivity, making it the best initial test to rule out SLE 2
- ANA testing should only be performed in patients with unexplained involvement of two or more organ systems, as specified by the American College of Rheumatology, due to its low specificity 3
- A positive ANA titer (particularly >1:160) warrants further specific testing 4
Confirmatory Tests
Anti-double stranded DNA (anti-dsDNA) antibodies:
- Highly specific for SLE (40-80% of patients) 2
- The Farr assay is considered the gold standard method for anti-dsDNA detection, though immunofluorescence on Crithidia Luciliae can be used as an alternative due to its high specificity 2
- ELISA methods should be used cautiously in the diagnostic phase due to lower specificity 2
Anti-Smith (anti-Sm) antibody:
Additional Specific Antibody Tests
Anti-extractable nuclear antigens (ENA) including:
Antiphospholipid antibodies:
Monitoring Tests
- Anti-dsDNA antibody levels (quantitative) are useful for monitoring disease activity, particularly in patients with nephritis 2
- Complement levels (C3, C4) should be monitored regularly 1
- Complete blood count (CBC) 1
- Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) 4
- Urinalysis and urine protein/creatinine ratio 1
Testing Protocol
- Start with ANA testing in patients with suggestive clinical features (photosensitive rash, symmetric inflammatory joint pain, unexplained cytopenias, multisystem inflammatory disease) 6
- If ANA is positive (especially at titers >1:160), proceed with specific antibody testing:
- Anti-dsDNA
- Anti-Sm
- Anti-ENA panel (Ro/La/RNP)
- Complement levels (C3, C4)
- For patients with suspected antiphospholipid syndrome, add:
- Lupus anticoagulant testing
- Anti-cardiolipin antibodies
Important Considerations and Pitfalls
- ANA has high sensitivity but low specificity - positive results are common in other autoimmune diseases and even healthy individuals 2, 3
- Anti-dsDNA ELISA methods may yield false positives; confirmation with Farr assay or Crithidia method is recommended for questionable results 4
- Patients with persistent, characteristic multisystem involvement but negative ANA should be evaluated for possible ANA-negative lupus 3
- Serial monitoring should be done using the same laboratory and assay method due to significant inter-laboratory and inter-method variability 4
- Lupus anticoagulant testing should be performed before starting anticoagulant therapy or after a sufficient period following discontinuation 1